This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Grifols SA (GRFS)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 0.00 0.00 0.00 0.00
Operating Gains/Losses 18.60M 9.88M 18.45M 26.48M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 32.71M -49.29M 58.53M -70.17M
(Increase) Decrease in Inventories -117.98M 23.86M 19.19M 8.95M
(Increase) Decrease In Other Current Assets -3.05M -3.61M -7.47M 12.08M
(Decrease) Increase In Payables 204.18M 84.73M -127.94M -17.32M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 825.53M 574.52M 539.13M 207.94M
Net Cash From Continuing Operations 1.19B 817.49M 670.67M 285.44M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.19B 817.49M 670.67M 285.44M
Sale of Property, Plant & Equipment 17.54M 23.19M 105.66M 207.72M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -349.04M -238.68M -219.71M -207.24M
Acquisitions -1.50B -95.52M -14.64M -2.11B
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 -14.92M 0.00 394.01K
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.85B -325.93M -85.22M -2.10B
Issuance of Debt 6.32B 0.00 34.02M 3.88B
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 186.68M 6.86M 0.00
Repayment of Long-Term Debt -4.83B -183.55M -372.02M -1.60B
Repurchase of Capital Stock -84.21M -138.04M -6.87M -3.67M
Payment of Cash Dividends -189.71M -96.75M 0.00 0.00
Other Financing Charges, Net -194.52M 86.46M -65.80M -369.06M
Net Cash From Financing Activities 1.02B -145.19M -403.80M 1.91B
Effect of Exchange Rate Changes 86.86M -21.24M -6.10M 31.71M
Net Change in Cash & Cash Equivalents 450.37M 325.13M 175.55M 130.82M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for GRFS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

GRFS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs